• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        【进展|热点】分享参加6th International Symposium on CD1 and NKT Cells后的感想

        丁香园论坛

        1354
        如题,
        感觉级别挺很高的,据说Nature immunol.之后都会有简短综述报道
        http://www.certain.com/system/profile/web/index.cfm?PKwebID=0x2186723327&varPage=home

        PROGRAM & SPEAKERS

        Click here to download and view/print the complete symposium program schedule!

        <center> <span><strong>ARRIVAL DAY - SEPTEMBER 23, 2011 (FRIDAY) 7:00 PM - 8:00 PM</strong></span></center> <center> <em>Welcome Reception 6:00 PM-7:00 PM: Sheraton Chicago Hotel & Towers</em></center> <center> <em>Keynote Lecture 7:00 PM-8:00 PM: </em><strong>Michael Brenner, </strong>Harvard Medical School, USA</center> <center> <em>Potent self-antigens enable invariant NKT TCRs to interpret microbial danger signals</em></center> <center>  </center> <center>  </center> <center> <span><strong>DAY 1 - SEPTEMBER 24, 2011 (SATURDAY)</strong></span></center>

        Morning Session (8:00 AM - 12:00 PM):

        NKT Cells: Development and Homeostasis, Chairs: Albert Bendelac & Dale Godfrey

        Albert Bendelac,
        University of Chicago, USA

        Coordinated Induction of Egr2 and PLZF Controls NKT Lineage Development

        Giulia Casorati, Foundation San Raffaele, Italy (Short Talk)

        Mechanism controlling iNKT cell functional development

        Mihalis Verykokakis, University of Chicago, USA (Short Talk)

        Role of Id3 in Thymic NKT Cell Maturation

        J. Christoph Vahl, Max Plank Institute Martinsried, Germany (Short Talk)

        Probing Valpha1 4i-inherent autoreactivity by a peripheral TCR switch

        Sebastian Joyce, Vanderbilt University, USA

        Thymic Selection of NKT Cells

        Alan Baxter, James Cook University, Australia (Short Talk)

        Role of Peroxisomes in NKT Cell Biology

        Coffee Break


        Dale Godfrey, University of Melbourne, Australia

        Variations in 'Invariant' NKT Cells

        Masaru Taniguchi, Riken Research Center for Allergy and Immunology, Japan

        Early NKT Precursor

        Kristin Hogquist, University of Minnesota, USA

        Crosstalk Between NKT and Conventional T Cells

        H. Robson MacDonald, Ludwig Institute for Cancer Research, Switzerland

        Ly-49 Inhibitory Receptors Shape the Vbeta Repertoire of Developing Invariant NKT Cells

        Afternoon Session (2:00 PM - 5:30 PM):

        Structure; Antigen Processing and Presentation, Chairs: Erin Adams & Randy Brutkiewicz

        Randy Brutkiewicz,
        Indiana University, USA

        Cell Signaling Pathways that Control CD1d-Mediated Antigen Presentation

        Markus Moll, Karolinska Institute, Sweden (Short Talk)

        Viral interference with CD1-restricted immunity

        Peter Cresswell, Yale University, USA

        Lysophospholipids and CD1d recognition by NKT cells

        Gennaro De Libero, University of Basel, Switzerland

        Regulation of Lipid Antigen Presentation

        Martine Gilleron, Universite de Toulouse, France (Short Talk)

        Role of CD1e and Lipases in the Processing of Multi-Acylated Mycobacterial Lipid Antigens

        Coffee Break


        Erin Adams, University of Chicago, USA

        The Molecular Recognition of CD1d Presented Lysophospholipids by NKT Cells

        Jamie Rossjohn, Monash University, Australia

        NKT TCR Recognition of CD1d-restricted Ags

        Laurent Gapin, University of Colorado USA

        TCR-Ligand Affinity in NKT Development

        Dirk Zajonc, La Jolla Institute for Allergy and Immunology, USA

        Structural Basis of Microbial Lipid Recognition

        Poster Session I (5:30 PM - 7:30 PM)

        <center> <span><strong>DAY 2 - SEPTEMBER 25, 2011 (SUNDAY)</strong></span></center>

        Morning Session (8:00 AM - 12:00 PM):

        Effector Function/Immunoregulation by NKT Cell Subsets, Chairs: Masaru Taniguchi & Chyung-Ru Wang

        Kim Nichols,
        Children's Hospital of Philadelphia, USA (Short Talk)

        Conditional Elimination of SAP Reveals Selective Roles in Natural Killer T Cell Function

        Toshinori Nakayama, Chiba University, Japan

        NKT Cell-Mediated Regulation of Antigen-Specific Memory Th2 Cell Function

        Hiroshi Watarai, Riken Research Center for Allergy and Immunology, Japan (Short Talk)

        Development and Function of invariant NKT cells Producing Th2 and Th17 Cytokines

        Kamel Benlagha, INSERM, France

        Innate IL-17 Response of PLN NK1.T iNKT Cells to Bacteria

        Jenny Gumperz, University of Wisconsin, USA

        Immunoregulation by Human NKT Cells

        Coffee Break


        Chyung-Ru Wang, Northwestern University, USA

        Group 1 CD1 in T Cell Development and Anti-Microbial Immunity

        Christian Kurts, Institute of Molecular Medicine and Experimental Immunology, Germany

        NKT Cell-Mediated Lincensing of DCs for Cross-Priming

        Elizabeth Leadbetter, Trudeau Institute, USA (Short Talk)

        Visualizing the Splenic iNKT Cell Effector Program: Cross-Talk with DCs at the Marginal Zone

        Stephane Gerart, Hopital Necker Enfants-Malades, France (Short Talk)

        High Suceptibility of Invariant NKT cells to Apoptosis Is Controlled by XIAP

        Luc Van Kaer, Vanderbilt University, USA

        NKT Cell Activation and Anergy

        Afternoon Session (2:00 PM - 5:30 PM):

        Ligands and Vaccines, Chairs: Steve Porcelli & Facundo Batista

        Steve Porcelli,
        Albert Einstein College of Medicine, USA

        Structure-Activity Relationships of NKT Cell Ligands and their Use as Vaccine Adjuvants

        Li Bai, University of Science and Technology, China (Short Talk)

        Distinct Antigen-Presenting Cells Explain the Cytokine Bias of aGC Variants In Vivo

        Moriya Tsuji, Aaron Diamond AIDS Research Center, USA

        Clinical Development of a Novel CD1d-Binding NKT Cell Ligand as an Adjuvant

        Luc Teyton, Scripps Research Institute, USA

        Transport and Uptake of NKT Ligands

        Alena Donda, University of Lausanne, Switzerland (Short Talk)

        CD1d-Antitumor scFv Fusion Proteins Induce Efficient Tumor Cell Killing

        Coffee Break


        Facundo Batista, London Research Institute, UK

        Understanding how iNKTs Potentiate Specific Antibody Responses in vivo

        Paul Savage, Brigham Young University, USA (Short Talk)

        NKT Cell Adjuvants For Oligosaccharide Vaccines

        Dapeng Zhou, MD Anderson, USA

        Nanoparticle Delivery of NKT Ligands for Immunotherapy and Vaccines

        Dirk Elewaut, Ghent University, Belgium

        Galactose-Modified iNKT Cell Agonists Stabilized by an Induced Fit of CD1d Prevent Metastasis

        Poster Session II (5:30 PM - 7:30 PM)

        <center> <span><strong>DAY 3 - SEPTEMBER 26, 2011 (MONDAY)</strong></span></center>

        Morning Session (8:00 AM - 12:00 PM):

        Microbial Immunity, Chairs: Mitchell Kronenberg & Branch Moody

        Mitchell Kronenberg,
        La Jolla Institute for Allergy and Immunology, USA

        Microbial NKT Ligands

        Florian Winau, Harvard Medical School, USA

        NKT Cell Activation by Self

        Paul Kubes, University of Calgary, Canada

        Intravital Imaging of the NKT Response to Infection and Sterile Injury

        Claire Forestier, INSERM, France (Short Talk)

        Distinct iNKT cell Responses to Leishmania Parasites In Acute or Silent Visceral Leishmaniasis

        Shailbala Singh, MD Anderson, USA (Short Talk)

        Mucosal aGC Delivery Overcomes NKT Cell Anergy to Enable Priming and Boosting of Adaptive

        Responses

        Coffee Break


        Branch Moody, Harvard Medical School, USA

        New Mycobacterial Lipid Antigens that Activate Human T Cells in vitro and ex vivo

        Chetan Seshadri, University of Washington, USA (Short Talk)

        Human CD1A-deficiency is Associated with Susceptibility to Mycobacterial Disease

        Olivier Lantz, Institut Curie, France

        MAIT cells, a Conserved T-cell Subset with Anti-Microbial Activity

        Rick Blumberg, Harvard Medical School, USA

        Mechanisms of NKT Cell Mediated Regulation of Intestinal Inflammation

        Sebastian Zeissig, Harvard Medical School, USA (Short Talk)

        HBV Infection Alters Endogenous CD1d Antigens Leading to NKT Activation and Viral Clearance

        Luncheon Session (12:30 PM - 1:30 PM):

        Biotechnologies, Chair: Moriya Tsuji

        Vincent Serra,
        CEO CSO, Wittycell

        Novel Vaccine Adjuvants for Induction of Cellular and Humoral Immunity

        Maurice Zauderer, President & CEO, Vaccinex, Inc.

        NKT Cell based Therapeutic Strategies

        Alem Truneh, Co-founder & CSO, NKT Therapeutics, Inc.

        Development of First-In-Class Antibodies Targeting iNKT Cells for Treatment of Inflammatory Diseases and Cancer

        Afternoon Group Activity: 3:00PM - 4:30PM, Chicago River Boat Architecture Tour

        EVENING GALA DINNER: 6:00PM - 9:00PM, The Modern Wing, The Art Institute of Chicago


        <center> <strong><span>DAY 4 - SEPTEMBER 27, 2011 (TUESDAY</span></strong>)</center> <center>  </center> <center>  </center>
        Morning Session (8:00 AM - 12:00 PM):

        Autoimmune Diseases, Inflammation and Cancer,
        Chairs: Agnes Lehuen & Vincenzo Cerundolo

        Vincenzo Cerundolo,
        University of Oxford, UK

        NKT Suppression vs Activation in Infection and Cancer

        Paolo Dellabona, Foundation San Raffaele, Italy

        The CD1/T Cell Axis in Leukaemia Immune Surveillance

        Fred Finkelman, University of Cincinnati, USA (Short Talk)

        When and Why Are NKT Cells Required for Development of Airway Hyperresponsiveness

        Gerhard Wingender, La Jolla Institute for Allergy and Immunology, USA (Short Talk)

        Environmental Antigens for Invariant NKT cells and their Role in Airway Inflammation

        Hye-Young Kim, Harvard Medical School, USA (Short Talk)

        Innate Lymphoid Cells Responding to IL-33 Mediate Airway Hyperreactivity

        Lydia Lynch, Harvard Medical School, USA (Short Talk)

        Unique iNKT Cells are Enriched in Fat, and Protect Against Obesity-Induced Metabolic Disorder

        Coffee Break


        Agnes Lehuen, INSERM U561, France

        Regulatory Role of NKT Cells: from Viral Infection to Type 1 Diabetes

        Mikael Karlsson, Karolinska Institute, Sweden

        NKT Cells in Innate B Cell Activation

        Jochen Mattner, Cincinnati Children's Hospital Medical Center, USA

        Genetic Susceptibility to Infection-Induced Liver Autoimmunity

        Maria Leite-de-Moraes, CNRS, France (Short Talk)

        Donor-Derived Invariant NKT cell Recovery Inversely Correlates with Acute GVHD

        Shinichiro Motohashi, Chiba University, Japan (Short Talk)

        NKT Cell-Based Immunotherapy For Non-Small Cell Lung Cancer

        DEPARTURE - SEPTEMBER 27, 2011 (TUESDAY) NOON
        版主小舟儿留言:
        感谢分享,欢迎继续更新。
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序